Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

APOLIPOPROTEIN B - ANVISA Registration 10350840226

Access comprehensive regulatory information for APOLIPOPROTEIN B in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10350840226 and manufactured by DIASYS DIAGNOSTIC SYSTEMS GMBH & CO. The registration is held by BIOSYS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, ABBOTT IRELAND DIAGNOSTICS DIVISION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10350840226
Registration Details
ANVISA Registration Number: 10350840226
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

TruCal Apo B
Risk Class II

Registration Details

10350840226

25351639583201112

02220795000179

Company Information

Germany
PT: ALEMANHA

Dates and Status

Dec 26, 2011

VIGENTE

09/18/2025 19:00:01